九典制药(300705.SZ)：签署小分子镇痛药物YJ2301项目的《专利及技术转让协议》

Group 1 - The core point of the article is that Jiutian Pharmaceutical (300705.SZ) is enhancing its product pipeline and market competitiveness in pain management by signing a patent and technology transfer agreement with Suzhou Yuanju Pharmaceutical Technology Co., Ltd. [1] - The agreement involves the introduction of patents and technologies related to the small molecule analgesic drug YJ2301 project [1] - The total transfer fee for this transaction will not exceed 400 million RMB [1]